You are here
Hormone replacement therapy
Malignant neoplasm of the breast - Hormone replacement therapy Factor
Last reviewed for CCPS 05 October 2006.
Preliminary questions [23825]
21468 there is some evidence that hormone replacement therapy may be a factor in the development of the condition under consideration.
1169 — the veteran is a woman. the veteran has had hormone replacement therapy at some time. 8816 — the veteran has established the causal connection between the hormone replacement medication and VEA service for the clinical onset of malignant neoplasm of the breast. 8820 — the veteran has established the causal connection between the hormone replacement medication and eligible service for the clinical onset of malignant neoplasm of the breast. or 8819 — the veteran has established the causal connection between the hormone replacement medication and operational service for the clinical onset of malignant neoplasm of the breast. Clinical onset and operational service [8819] 8823 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to operational service. Clinical onset and eligible service [8820]
8824 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to eligible service.